MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05234nmi a22003737a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20221026125752.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
|---|
| fixed length control field |
m||||| |||| 00| 0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
c| zz uauuu |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
180124d2022 sp ||||| |||| 00| 0 spa d |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
Salus Infirmorum |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Poveda Moratalla, Paula |
| 9 (RLIN) |
3831 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Alteraciones menstruales tras la vacunación de la Covid 19 / |
| Statement of responsibility, etc. |
Paula Poveda Moratalla; tutora: Elena Jiménez García |
| Medium |
[Trabajo Fin de Grado] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Date of publication, distribution, etc. |
2022 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 archivo (pdf.) ; |
| Dimensions |
1,80 MB |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Trabajo fin de grado. Defendido en 2022 |
| 520 3# - SUMMARY, ETC. |
|---|
| Summary, etc. |
Introducción: El SARS-CoV-2 o COVID-19 es una enfermedad respiratoria que <br/>genera una respuesta inflamatoria con sintomatología desde leve a grave. No <br/>existe ningún fármaco curativo, pero sí que consiga un mejor pronóstico. La <br/>vacuna genera inmunidad y nos prepara ante una posible infección. Cada una <br/>tiene un mecanismo de acción diferente, las más conocidas son <br/>Pfizer/BioNTech, Moderna, AstraZeneca y Johnson & Johnson. Los efectos <br/>secundarios más comunes son de sintomatología leve. En la población femenina <br/>se han descrito efectos secundarios a nivel hormonal también. <br/>El ciclo menstrual femenino dura aproximadamente 28 días. Se divide en ciclo <br/>ovárico (fase lútea y folicular) y en ciclo endometrial (fase proliferativa, fase <br/>secretora y menstruación). <br/>Objetivo: Identificar la aparición de alteraciones menstruales en población fértil <br/>tras recibir alguna de las dosis de la vacuna contra la Covid-19. <br/>Metodología: Estudio descriptivo de corte transversal con metodología <br/>cualitativa. <br/>Resultados: Se ha empleado Chi-cuadrado para el análisis. Las únicas <br/>variables que guardan relación al obtenerse un nivel de significación p<0,05 son <br/>aparición de trastornos en la menstruación con el consumo de anticonceptivos <br/>hormonales y pasar la enfermedad previamente con sufrir alteraciones <br/>menstruales posteriormente. El resto de variables al relacionarse se obtiene que <br/>no guardan relación al tener valores de significación p>0,05. <br/>Conclusiones: La mayor parte de las mujeres encuestadas han padecido <br/>alteraciones en su ciclo tras vacunarse con primera y segunda dosis <br/>manifestando sintomatología a nivel de sangrado, duración y premenstrual. <br/>Pasar la enfermedad previamente y a continuación vacunarse tiene más riesgo <br/>de padecer alteraciones. La aparición de trastornos en el ciclo menstrual tras la <br/>vacunación y el consumo de anticonceptivos guarda relación. Al relacionar la <br/>variable demográfica edad con la aparición de trastornos menstruales no se han <br/>extraído datos de interés.<br/> |
| 520 8# - SUMMARY, ETC. |
|---|
| Summary, etc. |
Introduction: SARS-CoV-2 or COVID-19 is a respiratory disease that generates <br/>an inflammatory response with mild to severe symptomatology. There is no <br/>curative drug, but it does provide a better prognosis. The vaccine generates <br/>immunity and prepares us for possible infection. Each has a different mechanism <br/>of action, the best known being Pfizer/BioNTech, Moderna, AstraZeneca and <br/>Johnson & Johnson. The most common side effects are of mild symptomatology. <br/>Hormonal side effects have also been reported in the female population. <br/>The female menstrual cycle lasts approximately 28 days. It is divided into an <br/>ovarian cycle (luteal and follicular phase) and an endometrial cycle (proliferative <br/>phase, secretory phase and menstruation). <br/>Objective: To identify the appearance of menstrual alterations in the fertile <br/>population after receiving any of the doses of the Covid-19 vaccine.<br/>Methodology: Descriptive cross-sectional study with qualitative methodology. <br/>Results: Chi-square was used for the analysis. The only variables that were <br/>related with a significance level of p<0.05 were the appearance of menstrual <br/>disorders with the consumption of hormonal contraceptives and having the <br/>disease before and suffering menstrual disorders afterwards. The rest of the <br/>variables when related it is obtained that they are not related as they have <br/>significance values p>0.05.<br/>Conclusions: Most of the women surveyed have suffered alterations in their <br/>cycle after being vaccinated with the first and second doses, manifesting <br/>symptoms at the level of bleeding, duration and premenstrual. Passing the <br/>disease previously and then being vaccinated has a higher risk of suffering <br/>alterations. The appearance of disorders in the menstrual cycle after vaccination <br/>and the consumption of contraceptives is related. When relating the demographic <br/>variable age with the appearance of menstrual disorders, no data of interest have <br/>been extracted |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
vacunación |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
menstruación |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Covid-19 |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
efecto secundario |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
trastornos de la menstruación |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
SARS-CoV-2 |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
vaccination |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
menstruation |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Covid-19 |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
side effects |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
menstrual disorders |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
SARS-CoV-2 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Jiménez García, Elena |
| 9 (RLIN) |
3017 |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Universidad Pontificia de Salamanca. |
| Subordinate unit |
Facultad de Enfermería y Fisioterapia Salus Infirmorum. |
| -- |
Grado en Enfermería. |
| 9 (RLIN) |
489 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Universal Decimal Classification |
| Koha item type |
TFG/TFM |
